The US Federal Trade Commission has filed a lawsuit against several pharmaceutical companies for delaying the release of a cheaper form of a medication, a conspiracy known as pay-for-delay agreements.
Reports say the FTC filed its suit against brand name pharmaceutical companies AbbVie and Besins Healthcare, as well as against generic maker Teva Pharmaceuticals, with accusations the companies agreed to delay the release of the generic form of a testosterone replacement therapy cream. In pay-for-delay agreements, brand name companies pay their generic counterparts from delaying the release of their cheaper drugs for sale.
The FTC’s allegations include claims of restraint of trade against companies.
In the wake of a high-profile pay-for-delay case that reached the US Supreme Court, FTC v. Actavis, a precedent was set that determined large cash settlement pay-for-delay deals were anticompetitive.
Now, the industry is awaiting a ruling by the US Court of Appeals for the Third Circuit, which will hear the appeal of a lawsuit that was dismissed because the pay-for-delay deal did not involve a cash settlement.
Full content: The Legal Intelligencer
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI